Please login to the form below

Not currently logged in


This page shows the latest sitagliptin news and features for those working in and with pharma, biotech and healthcare.

Reference price bill tabled in US House and Senate

Reference price bill tabled in US House and Senate

savings for several other drugs including Pfizer’s hormone replacement therapy Premarin (conjugated oestrogens),   Merck &Co’s Januvia (sitagliptin) for diabetes, and Astellas/Pfizer’s prostate cancer therapy Xtandi (enzalutamide).

Latest news

More from news
Approximately 8 fully matching, plus 83 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....